Lv11
98 积分 2024-08-12 加入
Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer’s Disease: A U.S. Cost Comparison Model
4天前
待确认
Economic evaluation of antibody-drug conjugates (ADCs) in patients with breast cancer: systematic review
1个月前
已完结
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis
2个月前
已完结
Safety profile of trastuzumab originator vs biosimilars: a systematic review and meta-analysis of randomized clinical trials
2个月前
已完结
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis
4个月前
已完结
[Comparison of the efficacy, safety, and cost-effectiveness of trastuzumab biosimilar HLX02 and the originator combined with pertuzumab and chemotherapy in the neoadjuvant treatment of patients with HER-2-positive breast cancer]
4个月前
已完结
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis
4个月前
已完结
Trastuzumab-Deruxtecan (T-DXd; DS-8201) vs trastuzumab emtansine (T-DM1) in high-risk patients with HER2-positive, residual invasive early breast cancer (BC) after neoadjuvant therapy (NAT): a randomized, phase 3 trial (DESTINY-Breast05)
6个月前
已完结
皖公网安备34019202002308
